<?xml-stylesheet type='text/xsl' href='rsspretty.xsl' version='1.0'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.law360.com/company_articles/1703" rel="self" type="application/rss+xml"/>
    <title>Law360: Guidant</title>
    <link>http://www.law360.com/</link>
    <description>Latest articles for organization: Guidant</description>
    <copyright>Copyright 2009 Portfolio Media, Inc.</copyright>
    <language>en-US</language>
    <image>
      <url>http://www.law360.com/images/headings/logo.gif</url>
      <title>Law360</title>
      <link>http://www.law360.com/</link>
    </image>
    <item>
      <title>Boston Scientific To Pay $296M To Settle Probe</title>
      <link>http://www.law360.com/articles/132778</link>
      <description>Boston Scientific Corp. subsidiary Guidant Corp. will plead guilty to two misdemeanor charges and pay $296 million to end a U.S. Department of Justice probe into cardiac defibrillator product advisories it issued. 
</description>
      <guid>http://www.law360.com/articles/132778</guid>
    </item>
    <item>
      <title>Guidant Investors Lose Bid To Revive Class Action</title>
      <link>http://www.law360.com/articles/129650</link>
      <description>Guidant Corp. has prevailed in a challenge by investors to the dismissal of a putative securities class action that alleged the medical device maker glossed over problems with its defibrillators and their impact on its aborted merger with Johnson &amp; Johnson, leading to billions of dollars in shareholder losses.</description>
      <guid>http://www.law360.com/articles/129650</guid>
    </item>
    <item>
      <title>Guidant Found Not Liable In Shocking Pacemaker Suit</title>
      <link>http://www.law360.com/articles/123611</link>
      <description>Boston Scientific Corp. unit Guidant Corp. has won a suit against a Pennsylvania pacemaker recipient who claimed that Guidant representatives present at the operation to install the device failed to correct an alleged error by the doctor.</description>
      <guid>http://www.law360.com/articles/123611</guid>
    </item>
    <item>
      <title>Guidant Cleared In Death Of Toddler With Pacemaker</title>
      <link>http://www.law360.com/articles/121524</link>
      <description>Guidant Corp., a subsidiary of Boston Scientific Corp., has been found not liable by an Indiana county jury in a wrongful death suit brought by the family of a 14-month-old girl who died in 2005 after a Guidant pacemaker was implanted in her heart. </description>
      <guid>http://www.law360.com/articles/121524</guid>
    </item>
    <item>
      <title>Method Patents Not Covered By 271(f): Fed. Circ.</title>
      <link>http://www.law360.com/articles/117463</link>
      <description>In Cardiac Pacemakers Inc.&#8217;s long-running patent infringement fight against St. Jude Medical Inc. over implantable defibrillators, a federal appeals court has ruled en banc that a statute used by patent holders to assert patents to products originating in the U.S. and assembled in other countries does not apply to method patents.</description>
      <guid>http://www.law360.com/articles/117463</guid>
    </item>
    <item>
      <title>Weighing Layoffs After Mergers And Acquisitions</title>
      <link>http://www.law360.com/articles/108826</link>
      <description>What happens when layoffs are made in connection with a merger or acquisition and the employer seeks releases from the terminated employees, particularly for age discrimination claims? There are certain issues that companies should consider when faced with this scenario, say Cheryl R. Saban and Christopher Reilly of Paul Hastings Janofsky &amp; Walker LLP.</description>
      <guid>http://www.law360.com/articles/108826</guid>
    </item>
    <item>
      <title>Device Makers Engaged In Off-Label Scheme: Suits</title>
      <link>http://www.law360.com/articles/111322</link>
      <description>A group of major medical device makers carried out a coordinated nationwide sales campaign to entice physicians and hospitals to use their products for off-label purposes, causing increased Medicare costs due to inappropriate inpatient surgical procedures, according to complaints unsealed Monday.</description>
      <guid>http://www.law360.com/articles/111322</guid>
    </item>
    <item>
      <title>Guidant Judge Rejects 3rd Party Payor Claims Again</title>
      <link>http://www.law360.com/articles/109504</link>
      <description>A federal judge has refused to reconsider a 2007 dismissal of proposed class action claims third-party health care providers brought against Guidant Corp. over its recalled implantable heart defibrillators, noting that much of the request was "an attempt to relitigate old issues."</description>
      <guid>http://www.law360.com/articles/109504</guid>
    </item>
    <item>
      <title>Last Acculink Claim Against Abbott Nixed</title>
      <link>http://www.law360.com/articles/109474</link>
      <description>A federal judge has thrown out the lone remaining claim in a product liability lawsuit brought by a man who was partially blinded during a stent procedure in which Abbott Laboratories' blood clot-capturing Acculink system failed to prevent a stroke.</description>
      <guid>http://www.law360.com/articles/109474</guid>
    </item>
    <item>
      <title>Investor's $70M Suit V. Abbott Sent To Arbitration</title>
      <link>http://www.law360.com/articles/103838</link>
      <description>An appellate court has dismissed a $70 million lawsuit accusing Abbott Laboratories of cheating a Cayman Islands-based investment firm out of royalties when the pharmaceutical company stopped developing the ZoMaxx stent, sending the dispute into arbitration.</description>
      <guid>http://www.law360.com/articles/103838</guid>
    </item>
    <item>
      <title>Judge Blasts Plaintiffs' Lawyer In Guidant MDL</title>
      <link>http://www.law360.com/articles/102420</link>
      <description>A federal judge on Tuesday harshly criticized a lawyer representing over 300 plaintiffs taking part in a $240 million settlement with Guidant Corp. over its implantable defibrillators for not telling his clients how much they would receive under the settlement, and said the lawyer could face sanctions.</description>
      <guid>http://www.law360.com/articles/102420</guid>
    </item>
    <item>
      <title>Guidant Sues Rival, Ex-Workers Over Exodus</title>
      <link>http://www.law360.com/articles/101976</link>
      <description>Guidant Sales Corp. has asked a court to declare that 12 former employees breached their nondisclosure agreements by going to work for rival Biotronik Inc.</description>
      <guid>http://www.law360.com/articles/101976</guid>
    </item>
    <item>
      <title>Riegel Preempts Conn. Defibrillator Suit: Court</title>
      <link>http://www.law360.com/articles/100320</link>
      <description>Pointing to the U.S. Supreme Court's 2008 Riegel decision, a Connecticut appeals court has affirmed the dismissal of a product liability suit against Guidant Corp., finding that federal law regulating medical devices preempts defective design claims related to an implantable defibrillator.</description>
      <guid>http://www.law360.com/articles/100320</guid>
    </item>
    <item>
      <title>Guidant Fights 3rd-Party Payors' Class Action Appeal</title>
      <link>http://www.law360.com/articles/97903</link>
      <description>Guidant Corp. is lashing out at a bid by third-party health care providers to appeal the dismissal of their proposed class action claims against the company over its recalled implantable heart defibrillators, arguing that the plaintiffs are "blatantly attempting to relitigate" issues previously decided by the court.</description>
      <guid>http://www.law360.com/articles/97903</guid>
    </item>
    <item>
      <title>French Antitrust Fines For Defibrillator Cos. Upheld</title>
      <link>http://www.law360.com/articles/96260</link>
      <description>A Paris appeals court has dismissed a suit by several defibrillator manufacturers, including Medtronic France, seeking to block a &#8364;2.6 million ($3.45 million) fine levied by France's antitrust regulator in connection with an alleged horizontal market-fixing scheme. </description>
      <guid>http://www.law360.com/articles/96260</guid>
    </item>
    <item>
      <title>Medtronic Gets OK To Seek Review Of Stent IP Ruling</title>
      <link>http://www.law360.com/articles/92616</link>
      <description>Medtronic Inc. has received the green light to ask a California federal court to reconsider a summary judgment ruling in its infringement case against Abbott Laboratories in which the court found that one of Medtronic's stent patents was anticipated by prior art.</description>
      <guid>http://www.law360.com/articles/92616</guid>
    </item>
    <item>
      <title>Fed. Circ. To Go En Banc For Method Claims Question</title>
      <link>http://www.law360.com/articles/90692</link>
      <description>Addressing an issue in a long-running intellectual property dispute between Guidant Corp. and St. Jude Medical Inc. over implantable defibrillators, the U.S Court of Appeals for the Federal Circuit is preparing to hold an en banc hearing over a question about companies&#8217; ability to extend their patent rights to activities overseas.</description>
      <guid>http://www.law360.com/articles/90692</guid>
    </item>
    <item>
      <title>3rd-Party Payers In Guidant Case Seek Appeal</title>
      <link>http://www.law360.com/articles/87327</link>
      <description>Third-party health care providers are asking a judge to consider allowing them to appeal the dismissal of their proposed class action claims against Guidant Corp. over its recalled implantable heart defibrillators, almost two years after the claims were dismissed.</description>
      <guid>http://www.law360.com/articles/87327</guid>
    </item>
    <item>
      <title>Medtronic Stent Patent Claims Not Indefinite: Judge</title>
      <link>http://www.law360.com/articles/86549</link>
      <description>A federal judge has issued a summary judgment ruling largely in favor of Medtronic Inc. as the medical device maker prepares to go to trial against Abbott Laboratories in an ongoing infringement suit over two stent patents.</description>
      <guid>http://www.law360.com/articles/86549</guid>
    </item>
    <item>
      <title>Divestiture Paves Way For Getinge, Datascope Merger</title>
      <link>http://www.law360.com/articles/85227</link>
      <description>Swedish medical giant Getinge AB has tentatively satisfied the Federal Trade Commission's concerns about its proposed $864 million takeover of rival Datascope Corp., which has agreed to unload a product line in exchange for agency approval of the deal. </description>
      <guid>http://www.law360.com/articles/85227</guid>
    </item>
  </channel>
</rss>
